Elite Pharmaceuticals announces Q1 FY2026 results release on Aug 14, conference call Aug 15

ELITE PHARMACEUTICALS INC /NV/

Financial results for Q1 FY2026 (ended June 30, 2025) to be released August 14, 2025.
Conference call to discuss results and provide corporate update on August 15, 2025 at 11:30 AM EDT.
Dial-in: 1-800-346-7359 (domestic) or 1-973-528-0008 (intl), conference ID 98840.
Stockholders can submit questions by email to dianne@elitepharma.com by deadlines: general by Aug 13, financial by Aug 14.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.